| (Values in U.S. Thousands) | Dec, 2015 | Sep, 2015 | Jun, 2015 | Mar, 2015 | Dec, 2014 |
| Sales | -9,999,000 | 9,460 | 9,730 | 8,030 | 9,090 |
| Sales Growth | -105,797.66% | -2.77% | +21.17% | -11.66% | +15.36% |
| Net Income | -9,999,000 | -13,580 | -14,860 | -15,640 | -14,490 |
| Net Income Growth | -73,530.34% | +8.61% | +4.99% | -7.94% | -4.32% |
Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Trivascular Technologies, Inc. is a medical device company. It is developing and commercializing technologies to significantly advance minimally invasive treatment of abdominal aortic aneurysms. The company offers ovation system, a stent graft platform for the treatment of AAA through minimally invasive endovascular aortic repair. It is also developing a short-cure fill polymer; next generation iliac limbs; ovation alto system, a next generation aortic body; and other platform applications. TriVascular Technologies, Inc. is headquartered in Santa Rosa, California.
Fiscal Year End Date: 12/31